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The innate immune system utilizes pattern-recognition
receptors (PRRs) to detect the invasion of pathogens and
initiate host antimicrobial responses. Recently, it was
reported that human cancer cells also expressed PRRs,
and responded to cytosolic nucleic acids via the produc-
tion of type I interferon and apoptosis in susceptible cells.
However, the definite nucleic acids senses in different
cancer cells remains unclear. In this study, we investigated
the effects of nucleic acids in eight types of cancer cells,
including pancreatic cancer, glioma, breast cancer, lung
cancer, hepatoma, gastric cancer, colorectal cancer, and
cervical cancer. We found that IFN-b secretion was
increased after poly(I:C) and poly(dA:dT) stimulation. In
order to understand the mechanism, we established the
role of TLR3 and RIG-I/MDA-5 signaling in pancreatic
cancer cell line PANC-1. poly(I:C) and poly(dA:dT) upre-
gulated the expression of PKR, TLR3, RIG-I, MDA5 and
LGP2. Knockdown experiments confirmed PKR, TLR3,
TRIF, RIG-I, LGP2, and IPS-1 involved in response to
cytosolic poly(I:C) and poly(dA:dT). In addition, poly(I:C)
and poly(dA:dT) induced apoptosis via caspase-8 and
caspase-9 in pancreatic cancer cells. In summary, cytosolic
poly(I:C) and poly(dA:dT) induce IFN-b secretion via
TLR3-TRIF and RIG-I/LGP2-IPS-1 signaling pathway and
apoptosis in a caspase-dependent manner at cancer cells.
This study may provide a novel way for drug and vaccine
design on cancer immunotherapy.
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